Reduction of creatine kinase and creatine kinase-MB indexes of infarct size by intravenous verapamil
- 30 November 1984
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 54 (10) , 1224-1230
- https://doi.org/10.1016/s0002-9149(84)80071-5
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- A randomized prospective trial of intravenous nitroglycerin in patients with acute myocardial infarction.Circulation, 1983
- Myocardial protection through cold cardioplegia with potassium or diltiazem. Experimental evidence that diltiazem provides better protection even when coronary flow is impaired by a critical stenosis.Circulation, 1982
- Limitation of infarct size in acute myocardial infarction with metoprololThe American Journal of Cardiology, 1982
- Comparative investigation of the effects of metoprolol, propranolol, practolol, and verapamil in the acute phase of experimental myocardial infarctionJournal of Molecular Medicine, 1982
- Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerin.Circulation, 1981
- Reduction of enzyme levels by propranolol after acute myocardial infarction.Circulation, 1978
- Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs.Circulation, 1977
- Bestimmung der Aktivit t von Creatinkinase MB im Serum unter Verwendung inhibierender Antik rperKlinische Wochenschrift, 1976
- Reduction of the size of acute, experimental myocardial infarction by VerapamilBasic Research in Cardiology, 1975
- Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activityJournal of Clinical Investigation, 1971